Literature DB >> 20354841

Modified camouflage therapy in an adult class I patient with TMJ complaints. A case report.

Douglas E Toll1, Nenad Popović, Jasminka Andjelić, Nicole Drinkuth.   

Abstract

The present case report documents the hitherto unusual application of camouflage orthodontics in one of our patients. Our female patient had previously been treated orthodontically alio loco and had also undergone bimaxillary orthognathic surgery. She presented with TMJ complaints, with associated pains. Despite a dental Class I and centrally seated condyles, her discs had prolapsed anteriorly without reduction and she had developed a massive degenerative-inflammatory TMJ disease. Skeletally, she was a Class II case despite previous orthognathic surgery. In addition, there was also an initial suspicion of rheumatic involvement that could not be confirmed. We distalized the entire lower dental arch without bicuspid extraction. Then we advanced the mandible with the Mandibular Anterior Repositioning Appliance (MARA).We discuss exactly how the modified camouflage therapy was structured and how the individual treatment steps took place.

Entities:  

Mesh:

Year:  2010        PMID: 20354841     DOI: 10.1007/s00056-010-9948-4

Source DB:  PubMed          Journal:  J Orofac Orthop        ISSN: 1434-5293            Impact factor:   1.938


  8 in total

1.  Long-term follow-up of Class II adults treated with orthodontic camouflage: a comparison with orthognathic surgery outcomes.

Authors:  Colin A Mihalik; William R Proffit; Ceib Phillips
Journal:  Am J Orthod Dentofacial Orthop       Date:  2003-03       Impact factor: 2.650

2.  Camouflage might not mean compromise.

Authors:  David L Turpin
Journal:  Am J Orthod Dentofacial Orthop       Date:  2003-03       Impact factor: 2.650

3.  Orthognathic surgery and dentofacial orthopedics in adult Class II Division 1 treatment: mandibular sagittal split osteotomy versus Herbst appliance.

Authors:  Sabine Ruf; Hans Pancherz
Journal:  Am J Orthod Dentofacial Orthop       Date:  2004-08       Impact factor: 2.650

4.  Effects of camouflage treatment on dentofacial structures in Class II division 1 mandibular retrognathic patients.

Authors:  Abdullah Demir; Tancan Uysal; Zafer Sari; Faruk Ayhan Basciftci
Journal:  Eur J Orthod       Date:  2005-07-27       Impact factor: 3.075

5.  A comparison of outcomes of orthodontic and surgical-orthodontic treatment of Class II malocclusion in adults.

Authors:  W R Proffit; C Phillips; N Douvartzidis
Journal:  Am J Orthod Dentofacial Orthop       Date:  1992-06       Impact factor: 2.650

6.  The use of MRI diagnostics in orthognathic surgery: prevalence of TMJ pathologies in Angle Class I, II, III patients.

Authors:  Douglas Edward Toll; Nenad Popović; Nicole Drinkuth
Journal:  J Orofac Orthop       Date:  2010-02-05       Impact factor: 1.938

7.  Treatment effects of the mandibular anterior repositioning appliance on patients with Class II malocclusion.

Authors:  Valmy Pangrazio-Kulbersh; Jeffrey L Berger; David S Chermak; Richard Kaczynski; Eugene S Simon; Andre Haerian
Journal:  Am J Orthod Dentofacial Orthop       Date:  2003-03       Impact factor: 2.650

8.  Class II treatment in adults: comparing camouflage orthodontics, dentofacial orthopedics and orthognathic surgery--a cephalometric study to evaluate various therapeutic effects.

Authors:  Gero Kinzinger; Linda Frye; Peter Diedrich
Journal:  J Orofac Orthop       Date:  2009-02-05       Impact factor: 1.938

  8 in total
  2 in total

1.  Treatment and posttreatment outcomes induced by the Mandibular Advancement Repositioning Appliance; a controlled clinical study.

Authors:  Luis Tomas Huanca Ghislanzoni; Douglas Edward Toll; Efisio Defraia; Tiziano Baccetti; Lorenzo Franchi
Journal:  Angle Orthod       Date:  2011-02-07       Impact factor: 2.079

2.  A comparison of the MARA and the AdvanSync functional appliances in the treatment of Class II malocclusion.

Authors:  Thikriat S Al-Jewair; Charles B Preston; Eva-Maria Moll; Terry Dischinger
Journal:  Angle Orthod       Date:  2012-01-03       Impact factor: 2.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.